| Identification | Back Directory | [Name]
(8-benzoyl-5-oxo-2,3,6,7-tetrahydro-5H-[1,3]thiazolo[3,2-a]pyridin-6-yl)acetic acid | [CAS]
861224-48-8 | [Synonyms]
5H-Thiazolo[3,2-a]pyridine-6-acetic acid, 8-benzoyl-2,3,6,7-tetrahydro-5-oxo-
(8-benzoyl-5-oxo-2,3,6,7-tetrahydro-5H-[1,3]thiazolo[3,2-a]pyridin-6-yl)acetic acid | [Molecular Formula]
C16H15NO4S | [MOL File]
861224-48-8.mol | [Molecular Weight]
317.36 |
| Chemical Properties | Back Directory | [Boiling point ]
580.2±50.0 °C(Predicted) | [density ]
1.44±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
4.21±0.10(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis[1]. | [References]
[1] Xuehui Long, et al. Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity. Nat Immunol. 2024. DOI:10.1038/s41590-024-01746-8 |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|